These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4190665)

  • 1. Jaundice of the newborn.
    Connon AF
    Postgrad Med; 1970 Mar; 47(3):193-7. PubMed ID: 4190665
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in treatment of RH negative blood incompatibility of mothers and infants.
    Chinn PC; Mueller JM
    Ment Retard; 1971 Feb; 9(1):12-5. PubMed ID: 4995878
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of the Rh affected baby.
    Rice MS
    Australas Nurses J; 1975 May; 3(11):12, 19. PubMed ID: 806279
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in prophylaxis and therapy of Rh-erythroblastosis.
    Thomsen K
    Nihon Sanka Fujinka Gakkai Zasshi; 1969 Aug; 21(8):911-2. PubMed ID: 4186822
    [No Abstract]   [Full Text] [Related]  

  • 5. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbilirubinemia secondary to hemolysis of intrauterine intraperitoneal blood transfusion.
    Rajagopalan I; Katz BZ
    Clin Pediatr (Phila); 1984 Sep; 23(9):511-2. PubMed ID: 6467786
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of neonatal jaundice: exchange transfusion and intrauterine transfusion].
    Kanaoka T
    Kango Gijutsu; 1975 Feb; 21(2):28-37. PubMed ID: 1037870
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE PROPHYLAXIS OF HEMOLYTIC DISEASE OF THE NEWBORN DUE TO RH FACTORS].
    LANZONE P; VALENZI M
    Quad Clin Ostet Ginecol; 1963 Nov; 18():971-7. PubMed ID: 14106693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Present status of anti Rh isoimmunization. General review].
    Mateu-Aragones JM
    Acta Obstet Ginecol Hisp Lusit; 1968; 16(1):52-78. PubMed ID: 4190331
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemolytic anaemia in the newborn infant.
    Walker W
    Clin Haematol; 1975 Feb; 4(1):145-66. PubMed ID: 810288
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of phototherapy in the treatment of jaundice caused by ABO and Rh blood group incompatibility].
    Godula-Stuglik U; Ulman-Doniec I; Doniec Z; Grzybowski A
    Acta Haematol Pol; 1988; 19(1-2):86-91. PubMed ID: 3149117
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of the Rh-negative gravida.
    Charles AG; Alpern WM
    Am Fam Physician; 1971 Mar; 3(3):104-19. PubMed ID: 4101204
    [No Abstract]   [Full Text] [Related]  

  • 13. Salicylamide glucuronide formation in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
    Malaka-Zafiriu K; Tsiures I; Danielides B; Cassimos C
    Helv Paediatr Acta; 1973 Oct; 28(4):323-9. PubMed ID: 4202728
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the Rh-negative mother.
    Beck RP
    Can Med Assoc J; 1973 Nov; 109(9):903-4. PubMed ID: 4127213
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal and neonatal jaundice and hepatitis associated with intrauterine fetal transfusion.
    Hutchinson DL; Iskandar GB; Gaffney PC; Maxwell NG
    JAMA; 1965 Oct; 194(2):199-201. PubMed ID: 5897328
    [No Abstract]   [Full Text] [Related]  

  • 16. [The incidence of exchange transfusions and etiology of neonatal pathological jaundice].
    Senterre J; Delava S; Capelle A; Sodoyez-Goffaux F; André A; Brocteur J; Otto-Servais M; Bouillenne J
    Rev Med Liege; 1966 Dec; 21(24):657-63. PubMed ID: 4965604
    [No Abstract]   [Full Text] [Related]  

  • 17. Current management of hemolytic disease of the newborn infant.
    Naiman JL
    J Pediatr; 1972 Jun; 80(6):1049-59. PubMed ID: 4112666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of placental transfusion in the pathogenesis of neonatal jaundice and hyperbilirubinaemia.
    Várdi P
    Acta Chir Acad Sci Hung; 1967; 8(3):211-4. PubMed ID: 6083076
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperbilirubinemia secondary to delayed absorption of intraperitoneal blood following intrauterine transfusion.
    Bowman JM
    J Pediatr; 1982 Sep; 101(3):482-3. PubMed ID: 7108679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.